Skip to main content

Table 1 Genetic association models and disease risk

From: Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

Model Genotypes Controls Patients Adjusted OR (95% CI) P-value
Codominant G/G 56 (53.9%) 51 (46.4%) 1.00 0.044
  A/G 42 (40.4%) 41 (37.3%) 1.07 (0.60–1.90)  
  A/A 6 (5.8%) 18 (16.4%) 3.27 (1.20–8.88)  
Dominant G/G 56 (53.9%) 51 (46.4%) 1.00 0.28
  A/G–A/A 48 (46.1%) 59 (53.6%) 1.35 (0.79–2.30)  
Recessive G/G–A/G 98 (94.2%) 92 (83.6%) 1.00 0.013
  A/A 6 (5.8%) 18 (16.4%) 3.17 (1.20–8.34)  
Over-dominant G/G–A/A 62 (59.6%) 69 (62.7%) 1.00 0.64
  A/G 42 (40.4%) 41 (37.3%) 0.88 (0.51–1.52)  
Log-additive 1.48 (0.99–2.22) 0.053
  1. Data are presented as number (percentage). Adjusted odds ratio (OR) by age. Bold values indicate statistical significance at P-value < 0.05
  2. CI confidence interval